Minako Pazdera was named General Counsel of LB Pharmaceuticals on January 21, 2026, according to GlobeNewswire.
LB Pharmaceuticals (Nasdaq: LBRX), a New York clinical-stage biopharmaceutical company focused on neuropsychiatric diseases, announced on January 21, 2026 that Dr. Minako Pazdera had been appointed General Counsel. She previously was General Counsel and Corporate Secretary at Kardigan and, before that, at Carmot Therapeutics, where she led the legal function through its acquisition by Roche. (Source: GlobeNewswire.)
Industry: Biopharmaceuticals · Location: New York, NY · Date: January 21, 2026
Looking for GC or CLO openings? General counsel & CLO jobs · Deputy GC jobs
Who is the general counsel of LB Pharmaceuticals?
Minako Pazdera took the General Counsel role at LB Pharmaceuticals in January 2026, as reported by GlobeNewswire. Legal leadership changes often, so check LB Pharmaceuticals’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.
More general counsel moves
- Francesca Campbell Named Senior Vice President, General Counsel and Corporate Secretary of Stanley Black & Decker (January 30, 2026)
- Alex Rose Named General Counsel and Chief Commercial Officer of QII (January 29, 2026)
- Eve Konstan Named Executive Vice President, Chief Legal Officer and Secretary of SiriusXM (January 29, 2026)
- Adam Copley Named Executive Vice President, Chief Legal Officer and General Counsel of The Duckhorn Portfolio (January 26, 2026)
- Bruce Czachor Named General Counsel, Chief Compliance Officer and Secretary of Stardust Power (January 26, 2026)
Browse every appointment in the General Counsel Directory.
Does this information need updating? Email us at info@inhouseblog.com.